Category: Partners

• Gold equivalent production of 11,163 Gold Equivalent Ounces (“GEO”) for Q1

• Full year guidance of 55,000-60,000 GEO maintained

• Adjusted EBITDA of $4.8 million for Q1, 2025 and Cash balance over US$20m

• Management to host conference call on 29^th of May, 11AM EDT

TORONTO, ON / ACCESS Newswire / May 29, 2025 / Cerrado Gold Inc. (TSX.V:CERT)(OTCQX:CRDOF)(FRA:BAI0) (“Cerrado” or the “Company“) announces its operational and financial results for the first quarter (“Q1/25”) including its Minera Don Nicolas (“MDN“) gold mine in Santa Cruz Province, Argentina, and its Mont Sorcier High Purity DRI Iron Project in Quebec.

Production results for MDN were previously released on April 15, 2025. The Company’s financial results are reported and available on SEDAR+ (www.sedarplus.com) and the Company’s website (www.cerradogold.com).

Q1/25 MDN Operating Highlights

• Q1/25 production of 11,163 GEO and AISC of $1,932/oz

  • Unit costs set to decline as production increases (target US$1,500-1,700)

• Q1/25 Adjusted EBITDA of $4.8 million

• Record heap leach production of 6,897 GEO During the Quarter

• Secondary crusher operational and underground development started

Operational results for the first quarter saw gold production in line with Q1/24, with the heap leach operation reaching a new production record of 6,897 GEO for the quarter. The expanded crusher is now fully operational and the quantity of ore being placed on the pad has increased. With higher gold prices, the CIL plant continues to process lower-grade stockpiles and is planned to continue processing low grade stockpiles through Q2/25, after which it will be blended with new high-grade material from the underground mining operations which will increase the average grade throughput at the mill.

Mark Brennan, CEO and Chairman commented, “The results from the first quarter demonstrate robust and improving production from our Heap leach operations; delivering strong cashflow to support our growth initiatives. We have successfully expanded and improved our crushing capacity at MDN, which will yield greater production and cashflows moving forward. Likewise, the preparation for underground development and production have added costs but will add to our production and cash flows starting in July. The strong cash flow combined with our cash balance has enabled us to continue to pay down debt at MDN, and will allow us to continue to deploy capital at our high-grade Mont Sorcier DRI iron project and our well advanced and highly prospective Lagoa Salgada Project.”

Operating Results for the Quarter

The addition of the new crusher circuit was completed just after quarter end, providing increased ore availability to the pad. While supporting higher production, additional crushing facilities are also expected to reduce the feed size to the pad and thus improve recoveries. As the reduced size feed and larger pad stockpiles are leached, it should lead to higher production rates and unit costs are expected to decline as a result.

Post quarter end saw the initiation of activities at our underground operation. The Paloma pit has been dewatered, orders for long lead items have been placed and initial development of the portal commenced in May. The development of the underground remains on schedule for initial production during the 3^rd quarter of this year.

Cerrado has continued to make improvements to its balance sheet during the quarter. The cash balance remained strong at over US$20m as at March 31, 2025, while debt levels and payables continued to fall. The Company recently announced it had made the final payment to the Sellers of its MDN property, reducing an additional US$5m in debt.

The focus at MDN remains to ramp up production rates at its heap leach operation to 4,000-4,500 GEO per month, initiate underground production from the Paloma area in Q3, and ramp up a new targeted exploration program across our 330k Ha property targeted to increase resources and mine life. The Company is well positioned to continue its debt and payables reduction program at MDN as well as to fund future development and exploration at MDN and push forward its development projects in Quebec and in Portugal. In Portugal, we aim to complete the optimized feasibility study in Q3 and reach a construction decision by year end. In Quebec, work on advancing the feasibility study for the Mont Sorcier High grade iron project formally commenced during the quarter and remains on target for completion in Q1/2026.

Q1 Financial Performance

Table 1. Q1 2025 Operational and Financial Performance

The Company produced 11,163 gold equivalent ounces (“GEO”) during the three months ended March 31, 2025, as compared to 11,204 GEO for the three months ended March 31, 2024. Production is consistent with the prior year period. In the period ended March 31, 2025, heap leach production was significantly higher compared to prior year due to 36% higher gold head grade, 53% higher recovery and 462,000 additional tonnes placed on the pad. This was offset by a 6,136 ounce decrease in production from the CIL operation as the Company’s focus moved towards heap leach operations in 2025 and the plant only processed low grade ore in Q1 2025.

The Company generated revenue of $28.8 million for the three months ended March 31, 2025, from the sale of 10,992 ounces of gold and 42,623 ounces of silver at an average realized price per gold ounce sold of $2,520. For the three months ended March 31, 2024, the Company generated revenue of $20.4 million from the sale of 10,120 ounces of gold 18,749 ounces of silver. Revenue is higher for the three months ended March 31, 2025 as compared to the three months ended March 31, 2024, due primarily to higher production and the average realized gold price.

Cost of sales for the three months ended March 31, 2025, were $26.6 million as compared to $23.6 million for the three months ended March 31, 2024. The Company incurred $3.0 million higher production costs for the three months ended March 31, 2025 due to higher costs of equipment rentals, and higher labour costs in 2025 as compared to 2024.

Total cash costs (including royalties) per ounce sold was $1,902 per ounce in the three months ended March 31, 2025, as compared to $2,042 per ounce for the three months ended March 31, 2024 a $140 per ounce or 7% decrease (refer to reconciliation of Non-IFRS performance metrics). The decrease is a result of higher ounces sold in 2025 as compared to 2024.

Net loss from continued and discontinued operations for the three months ended March 31, 2025, was $4.2 million as compared to a net loss of $7.3 million for the three months ended March 31, 2024. The decrease in net loss is primarily a result of $8.4 million increase in metal sales, $0.4 million decrease in general and administrative expenses, offset by higher depreciation expense of $2.1 million and an increase in loss on remeasurement of MDN stream obligation of $1.4 million.

The Company incurred general and administrative expenses of $2.1 million for the three months ended March 31, 2025, as compared to $2.4 million of general and administrative expenses incurred during the three months ended March 31, 2024. The decrease was primarily as result of a decrease in stock-based compensation of $0.6 million, and professional fees of $0.1 million for the three months ended March 31, 2025.

Other loss of $3.7 million during the three months ended March 31, 2025, includes finance expense of $2.1 million and loss on fair value remeasurement of MDN stream obligation of $3.3 million offset by finance income of $0.9million and foreign exchange gain of $0.9 million.

Hedging Program

On April 26, 2025 the Company extended its limited hedging program with Ocean Partners UK Ltd. The hedge is constructed as a zero-cost collar with lower and upper boundaries of US$3,100 and US$3,250 per ounce respectively. The hedging volume is for 2,000 ounces per month for a period of 7 months beginning May 2025 and terminating on December 2025. With the expanded hedging program, the Company is focused on ensuring more than sufficient cash flows to further enhance its balance sheet and support funding requirements for its various growth projects.

Outlook

Entering the second quarter of 2025 and beyond, Cerrado’s MDN Heap Leach operations are set to benefit from the completion of its crushing infrastructure to grow and improve production. Higher gold prices have enabled the plant to remain operational by processing lower grade stockpiles through March and April. The underground operations have begun and production is expected to begin in Q3.

As noted in the Press Release dated April 15, 2025, the Company raised its 2025 annual production guidance to 55,000 – 60,000 GEO. AISC costs are expected to be modestly higher than previously anticipated with an AISC of between $1,500 – $1,700 per GEO. The increased costs are the result of the inclusion of underground mining, ongoing processing of low-grade ores and continued inflationary pressure in Argentina.

A new Exploration initiative began in Q1 with the focus on growing the known resources at MDN beyond those outlined in the recent Mineral Resource Estimate (“MRE”). The focus remains on defining high grade-near surface targets that can readily be brought into the mine plan, underground exploration and a regional program to better understand the potential of known anomalies on the significant land package Cerrado holds at MDN. Drilling is expected to commence in early June.

At the Mont Sorcier high grade and high purity DRI iron project operated by Cerrado’s wholly owned subsidiary Voyager Metals Inc., work continued to advance the project with several workstreams related to permitting, social license and the initiation of the Feasibility Study which is targeted to be completed during Q1 2026. The high quality of the concentrate, grading over 67% iron, from the Mont Sorcier project is well positioned to support growing demand from the global Green Steel transition due to the reduced emissions generated by steel producers using high grade concentrates.

The Company recently closed the acquisition of all of the outstanding common shares of Ascendant Resources Inc. not already owned by the Company. The Company will continue to advance the Lagoa Salgada VMS project through several key workstreams, including the ongoing metallurgical test work, which is currently on track to be completed towards the end of Q2 2025, completion of the optimized feasibility study by Q3 2025 and advancing the approval in the Environment Impact Assessment, expected to be received in June. The Company remains focused on advancing the Project to reach a construction decision , which is currently expected by year end.

Conference Call Details

Cerrado Management will host a conference call on May 29, 2025, at 11:00 AM EDT to discuss the Q1 Financial and Operational results. The presentation for the call can be found on the investor page on Cerrado Gold’s website at cerradogold.com. Call details are as follows:

Pre-Registration for Conference Call

Participants can preregister for the conference by navigating to:

https://dpregister.com/sreg/10200183/ff3862e66f

Participants will receive dial-in numbers to connect directly upon registration completion.

Those without internet access or unable to pre-register may dial in by calling:

PARTICIPANT DIAL IN (TOLL FREE): 1-833-752-3576

PARTICIPANT INTERNATIONAL DIAL IN: 1-647-846-8340

Review of Technical Information

The scientific and technical information in this press release has been reviewed and approved by Andrew Croal P.Eng, Chief Technical Officer for Cerrado Gold, who is a Qualified Person as defined in National Instrument 43-101.

About Cerrado

Cerrado Gold is a Toronto-based gold production, development, and exploration company. The Company is the 100% owner of the producing Minera Don Nicolás and Las Calandrias mine in Santa Cruz province, Argentina. In Portugal, the Company holds an 80% interest in the highly prospective Lagoa Salgada VMS project through its position in Redcorp – Empreendimentos Mineiros, Lda. In Canada, Cerrado Gold is developing its 100% owned Mont Sorcier Iron project located outside of Chibougamou, Quebec..

In Argentina, Cerrado is maximizing asset value at its Minera Don Nicolas operation through continued operational optimization and is growing production through its operations at the Las Calandrias heap leach project. An extensive campaign of exploration is ongoing to further unlock potential resources in our highly prospective land package in the heart of the Deseado Masiff.

In Portugal, Cerrado focused on the exploration and development of the highly prospective Lagoa Salgada VMS project located on the prolific Iberian Pyrite Belt in Portugal. The Lagoa Salgada project is a high-grade polymetallic project, demonstrating a typical mineralization endowment of zinc, copper, lead, tin, silver, and gold. Extensive exploration upside potential lies both near deposit and at prospective step-out targets across the large 7,209-hectare property concession. Located just 80km from Lisbon and surrounded by exceptional infrastructure, Lagoa Salgada offers a low-cost entry to a significant exploration and development opportunity, already showing its mineable scale and cashflow generation potential.

In Canada, Cerrado holds a 100% interest in the Mont Sorcier Iron project, which has the potential to produce a premium iron ore concentrate over a long mine life at low operating costs and low capital intensity. Furthermore, its high grade and high purity product facilitates the migration of steel producers from blast furnaces to electric arc furnaces, contributing to the decarbonization of the industry and the achievement of sustainable development goals.

For more information about Cerrado please visit our website at: www.cerradogold.com.

Mark Brennan
CEO and Chairman

Mike McAllister
Vice President, Investor Relations
Tel: +1-647-805-5662
mmcallister@cerradogold.com

Disclaimer

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This press release contains statements that constitute “forward-looking information” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.

Forward-looking statements contained in this press release include, without limitation, statements regarding the business and operations of Cerrado, anticipated continued improvements in operating results and working capital position, expectations regarding the CIL plant processing lower grade stockpiles, the potential for improvement at MDN’s heap leach operation, expectations regarding improvements in operating costs at MDN including AISC, additional capacity being added at the heap leach operation, the potential of and timing for the anticipated underground operation at MDN the anticipated timing of completing the feasibility study at the Mont Sorcier project, the potential for a construction decision at Lagoa Salgada by year end and the expected timing and likelihood of receiving approval of the environmental impact assessment at Lagoa Salgada.. In making the forward- looking statements contained in this press release, Cerrado has made certain assumptions. Although Cerrado believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurance that the expectations of any forward-looking statements will prove to be correct. Known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Except as required by law, Cerrado disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.

SOURCE: Cerrado Gold Inc.

View the original press release on ACCESS Newswire

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS.

CASCAIS, PORTUGAL / ACCESS Newswire / May 29, 2025 / Pulsar Helium Inc. (AIM:PLSR)(TSXV:PLSR)(OTCQB:PSRHF) (“Pulsar” or the “Company“), the helium project development company, is pleased to announce its financial and operating results for the six months ended March 31, 2025 (the “Period“).

Selected financial and operational information is outlined below and should be read in conjunction with the Company’s unaudited consolidated financial statements and related management’s discussion and analysis (the “MD&A“) for the Period, which are available on the Company’s website at www.pulsarhelium.com and the Company’s SEDAR+ profile at www.sedarplus.ca.

All figures are in US dollars (“US$“) unless otherwise stated.

The Company’s primary focus is the exploration and development of the Topaz Project, located in northern Minnesota, USA, close to the Canadian border. The Company’s assets within the Topaz Project comprise leases of private mineral rights over a total of 5,979 gross acres in Minnesota, where the State of Minnesota passed new helium-targeted legislation in May 2024 providing increased certainty of developing the project. The Topaz Project comprises primarily helium (with the gas not being a by-product of hydrocarbon production), representing a more sustainable development project.

Operational Highlights in the Period

• On January 13, 2025, the Company announced the successful completion of the deepening operation for the Jetstream #1 appraisal well. The drilling operation reached total depth (“TD”) of 5,100 feet (1,555 metres) on January 11, 2025, successfully penetrating the entire interpreted helium-bearing reservoir and beyond.

• On February 3, 2025, the Company announced the successful completion of a drilling operation at the Jetstream #2 appraisal well, reaching total depth of 5,638 feet (1,718 metres) on February 1, 2025. Mud log data reported helium levels up to 3.5%, which were proved to be contaminated with air and uncontaminated samples, once collected, are expected to report higher and truer levels.

• On February 20, 2025, the Company announced that down-hole testing equipment is scheduled to mobilise to site on February 24, 2025. The tools consist of an optical televiewer and LithoScanner, both of which will be run on both the Jetstream #1 and #2 appraisal wells. These tests will further refine the Company’s understanding of the reservoir properties and production potential.

• On April 28, 2025, the Company announced that pressure and flow testing operations were conducted on the Jetstream #1 and Jetstream #2 appraisal wells with well-head pressure at both being highly encouraging, reaching 122 pounds per square inch gauge (“PSIG”) at Jetstream #1 and 151 PSIG at Jetstream #2. Well-head pressure at Jetstream #2 is greater than Jetstream #1 was in February 2024 (145 PSIG) when it achieved a flow rate of 821,000 cubic feet per day, under well-head compression.

• During flow testing activities, it was discovered that drilling fines (rock dust) created by the air drilling method (that pulverizes the rock) were present within fractures and partially coating the wellbore wall. The creation of drilling fines is commonplace when air drilling. Although gas flow may be restricted, pressure communication still occurs (albeit also constrained) which is why the Company was unaware of the restricted flow until testing commenced.

• The Company has performed a preliminary clean-up on both wells to mobilise the drilling fines, achieving improved flow results, demonstrating that the drilling fines are mobile and can be removed. Despite the currently restricted conditions, stable and consistent flow rates were achieved with both wells flowing natural flow and on compression.

• Further flow testing of both wells will commence when clean-up is complete and the drilling fines have been removed.

Financial Summary for the Period

• Loss for the Period was $7,118,554 and comprises:

  • Administration costs of $1,955,208 (which includes non-cash share-based compensation of $299,943 and non-cash depreciation of $26,489).

  • Exploration and evaluation expenditures of $5,771,409 relate to the deepening of Jetstream #1 and drilling of Jetstream #2 at the Topaz project as described above.

  • Listing fees of $355,003 related to Admission.

  • A non-cash gain on revaluation of warrant liability of $963,006.

  • Funding and Cash Position: $1,659,888 at March 31, 2025.

• On October 18, 2024, the Company’s common shares commenced trading (the “Admission“) on the AIM market of the London Stock Exchange plc (“AIM“) under the symbol PLSR. Concurrent with Admission, the Company completed of a total gross funding of £5 million which included the £1.125 million cornerstone investment completed in August 2024.

• On January 9 and March 21, 2025, the Company completed a brokered private placement, in two tranches, for gross proceeds of $2,427,498 which included participation from high net worth and institutional investors from the USA, including University Bancorp, Inc. (“University Bancorp“) that now holds 4.93% of the issued and outstanding common shares of the Company.

• In April 2025, the Company entered into a project financing facility line of credit note with University Bancorp, pursuant to which University Bancorp has extended the Company a $4,000,000 project finance facility (the “Facility“). In April and May, 2025, the Company drew, in aggregate, $2,000,000 of the Facility.

Selected Financial Results

		Six months ended March 31, 2025				Six months ended March 31, 2024
Statement of Loss:
Revenue		$Nil				$Nil
Net loss		$	7,118,554			$	20,092,828
Basic and diluted loss per common share		$	0.06			$	0.24
Financial Position:
Total assets		$	2,941,370			$	2,910,871
Total liabilities		$	5,349,970			$	15,247,063

* During the Period, the Company recorded a non-cash gain on revaluation of warrant liability of $963,066 (2024 – loss of $13,037,216)

Thomas Abraham-James, President & CEO of Pulsar, commented: “We are extremely encouraged by the progress made at the Topaz Project during the first half of 2025. The successful drilling and flow testing of both Jetstream #1 and #2 appraisal wells, along with the positive well-head pressures recorded, reinforce the significant potential of our Topaz primary helium project. With the support of recent project financing and ongoing technical advancements, Pulsar is well-positioned to unlock further value for our shareholders and advance towards sustainable helium production.”

Marketing Engagement and Clarification on Marketing Engagement

The Company also announces the engagement of Oak Hill Financial Inc. (the “Oak Hill Engagement“).

Oak Hill Financial Inc. (“Oak Hill“) is a Toronto, Ontario, Canada based capital market advisory firm that provides advisory and capital markets services to private and public growth companies. The Company signed an agreement with Oak Hill on May 28, 2025, for a monthly fee of CAD$7,200, to be paid in cash, with the services commencing on June 2, 2025 (the “Effective Date“), and expiring 3 (three) months from the Effective Date, after which the agreement will renew on a month to month basis unless terminated by either party with five (5) days’ notice. Oak Hill has advised the Company that it does not hold any securities of or other interest in the Company. Oak Hill and the Company are unrelated and unaffiliated entities.

The Oak Hill Engagement remains subject to the approval of the TSX Venture Exchange.

Further to the Company’s news release dated April 7, 2025 which included an announcement of the Company’s engagement of VSA Capital Limited (“VSA Capital“), the Company advises that it engaged VSA Capital on April 4, 2025, and not on April 1, 2025, as previously disclosed. The Company also clarifies that it paid VSA Capital the £5,000 annual cash fee in full and in advance of VSA Capital providing services to the Company. All other terms relating to the engagement between the Company and VSA Capital remain unchanged and are as previously disclosed.

On behalf Pulsar Helium Inc.
“Thomas Abraham-James”
President, CEO and Director

Further Information:

Pulsar Helium Inc.
connect@pulsarhelium.com
+ 1 (218) 203-5301 (USA/Canada)
+44 (0) 2033 55 9889 (United Kingdom)
https://pulsarhelium.com
https://ca.linkedin.com/company/pulsar-helium-inc.

Strand Hanson Limited
(Nominated & Financial Adviser, and Joint Broker)
Ritchie Balmer / Rob Patrick / Richard Johnson
+44 (0) 207 409 3494

OAK Securities*
(Joint Broker)
Jerry Keen (Corporate Broking) / Henry Clarke (Institutional Sales) / Dillon Anadkat (Corporate Advisory)
info@OAK-securities.com
+44 203 973 3678

BlytheRay Ltd
(Financial PR)
Megan Ray / Said Izagaren
+44 207 138 3204
pulsarhelium@blytheray.com

*OAK Securities is the trading name of Merlin Partners LLP, a firm incorporated in the United Kingdom and regulated by the UK Financial Conduct Authority.

About Pulsar Helium Inc.

Pulsar Helium Inc. is a publicly traded company listed on the AIM market of the London Stock Exchange and the TSX Venture Exchange with the ticker PLSR, as well as on the OTCQB with the ticker PSRHF. Pulsar’s portfolio consists of its flagship Topaz helium project in Minnesota, USA, and the Tunu helium project in Greenland. Pulsar is the first mover in both locations with primary helium occurrences not associated with the production of hydrocarbons identified at each.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Qualified Person Signoff

In accordance with the AIM Note for Mining and Oil and Gas Companies, the Company discloses that Thomas Abraham-James, President, CEO and Director of the Company has reviewed the technical information contained herein. Mr. Abraham-James has approximately 20 years in the mineral exploration industry, is a Chartered Professional Fellow of the Australasian Institute of Mining and Metallurgy (FAusIMM CP (Geo)), a Fellow of the Society of Economic Geologists and a Fellow of the Geological Society of London.

Forward-Looking Statements

This news release and the interview contains forward-looking information within the meaning of Canadian securities legislation (collectively, “forward-looking statements”) that relate to the Company’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, “projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward-looking statements. Forward-looking statements herein include, but are not limited to, statements relating to the completion of the private placement, the independent resource estimate for helium and CO₂ at Topaz; the potential of CO₂ as a valuable by-product of the Company’s future helium production; the potential impact of deepening Jetstream #1 and the potential impact of such deepening on the next iteration of the resource estimate; the potential impact of the results of Jetstream #2; and the potential for future wells. Forward-looking statements may involve estimates and are based upon assumptions made by management of the Company, including, but not limited to, the Company’s capital cost estimates, management’s expectations regarding the availability of capital to fund the Company’s future capital and operating requirements and the ability to obtain all requisite regulatory approvals.

No reserves have been assigned in connection with the Company’s property interests to date, given their early stage of development. The future value of the Company is therefore dependent on the success or otherwise of its activities, which are principally directed toward the future exploration, appraisal and development of its assets, and potential acquisition of property interests in the future. Un-risked Contingent and Prospective Helium Volumes have been defined at the Topaz Project. However, estimating helium volumes is subject to significant uncertainties associated with technical data and the interpretation of that data, future commodity prices, and development and operating costs. There can be no guarantee that the Company will successfully convert its helium volume to reserves and produce that estimated volume. Estimates may alter significantly or become more uncertain when new information becomes available due to for example, additional drilling or production tests over the life of field. As estimates change, development and production plans may also vary. Downward revision of helium volume estimates may adversely affect the Company’s operational or financial performance.

Helium volume estimates are expressions of judgement based on knowledge, experience and industry practice. These estimates are imprecise and depend to some extent on interpretations, which may ultimately prove to be inaccurate and require adjustment or, even if valid when originally calculated, may alter significantly when new information or techniques become available. As further information becomes available through additional drilling and analysis the estimates are likely to change. Any adjustments to volume could affect the Company’s exploration and development plans which may, in turn, affect the Company’s performance. The process of estimating helium resources is complex and requires significant decisions and assumptions to be made in evaluating the reliability of available geological, geophysical, engineering, and economic date for each property. Different engineers may make different estimates of resources, cash flows, or other variables based on the same available data.

Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, that Pulsar may be unsuccessful in drilling commercially productive wells; the uncertainty of resource estimation; operational risks in conducting exploration, including that drill costs may be higher than estimates and the potential for delays in the commencement of drilling; commodity prices; health, safety and environmental factors; and other factors set forth above as well as under “Cautionary Note Regarding Forward Looking Statements and Market and Industry Data” and “Risk Factors” in the Final Prospectus dated July 31, 2023 filed on the Company’s profile on www.sedarplus.ca. Forward-looking statements contained in this news release are as of the date of this news release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. No assurance can be given that the forward-looking statements herein will prove to be correct and, accordingly, investors should not place undue reliance on forward-looking statements. Any forward-looking statements contained in this news release and interview are expressly qualified in their entirety by this cautionary statement.

SOURCE: Pulsar Helium Inc.

View the original press release on ACCESS Newswire

TORONTO, ON / ACCESS Newswire / May 28, 2025 / SPETZ INC. (the “Company” or “Spetz“) (CSE:SPTZ)(OTC PINK:DBKSF) is pleased to announce that it has held the closing of the first tranche of its previously announced non-brokered private placement (the “Private Placement“) at which it issued 14,702,617 units (the “Units“) at a price of $0.50 per Unit, for gross proceeds of $7,351,308.50. Each of the Units is comprised of one common share and one-half of a common share purchase warrant (the “Warrants“) of Spetz. Each whole Warrant entitles its holder to acquire one additional common share of Spetz at a price of $0.75 for a period of 24 months from the closing date. The Private Placement was described in the press releases of the Company disseminated on March 24, 2025 and May 12, 2025. The net proceeds from the Private Placement will be used for general working capital purposes, validator expansion, and growth initiatives within the blockchain infrastructure sector.

“We’re excited to announce the closing of this first tranche and the strong support we’ve received from a high-caliber group of investors,” said Mitchell Demeter, CEO and Director of Spetz Inc and Sonic Strategy. “These funds will enable the Company to acquire Sonic tokens, launch validator infrastructure to help secure the Sonic network, and deploy capital into DeFi strategies within the Sonic ecosystem. We’re especially pleased to have participation from key backers including Canaccord Genuity Financial, Russell Star, previously of DeFi Technologies, Haywood Securities, and Sonic Labs.”

Additional closings of the Private Placement may be held until June 23, 2025, subject to the issuance of a maximum of an additional 5,297,383 Units at a price of $0.50 per Unit, for total maximum additional gross proceeds of $2,648,691.50.

In connection with the Private Placement, Spetz paid cash commissions to seven (7) securities dealers in an aggregate amount of $315,812. In addition, Spetz granted non-transferable finders’ warrants (the “Finder’s Warrants”) to seven (7) securities dealers entitling them to acquire up to an aggregate of 719,524 additional common shares of Spetz at a price of $0.75 per share for a period of 24 months form the closing date.

All of the foregoing securities are subject to a hold period of four months and day expiring on September 29, 2025.

Related Party Transaction

Michael Kron, a director of the Company, purchased 100,000 Units at a price of $0.50 per Unit for a consideration of $50,000 (representing approximately 0.22% of the issued and outstanding common shares of the Company following the closing of the Private Placement). Immediately after the closing of the Private Placement, Mr. Kron owned, directly, 115,704 common shares of the Company, 50,000 Warrants and 10,000 stock options of the Company.

Mr. Kron is considered a “related party” and an “insider” of the Company for the purposes of applicable securities laws and stock exchange rules. The subscription and issuance of Units to Mr. Kron constitute a related party transaction, but is exempt from the formal valuation and minority approval requirements of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”) as the Company’s securities are not listed on any stock exchange identified in Section 5.5(b) of MI 61-101 and that the fair market value of the Units issued to Mr. Kron under the Private Placement, does not exceeds 25% of the Company’s market capitalization. The Company did not file a material change report with respect to the participation of Mr. Kron at least 21 days prior to the closing of the Private Placement as Mr. Kron’s participation was not determined at that time.

Mr. Kron, a director of the Company, has disclosed his interest to the Board of the Directors of the Company pursuant to Section 132 of the Business Corporations Act (Ontario) to the effect that he may participate in the Private Placement and subscribe to Units. The terms of the Private Placement and the agreements relating thereto were submitted to and unanimously approved by way of a written resolution adopted by all the directors of the Company other than Mr. Kron. Mr. Kron did not vote on the resolution to approve the Private Placement and the agreements relating thereto. The remaining directors determined that the Private Placement was in the best interest of the Company.

About Spetz Inc.
Spetz Inc. is a multinational technology company operating at the intersection of AI-driven marketplaces and blockchain infrastructure. The Company owns and operates the Spetz application, an AI-powered platform connecting consumers with service providers, as well as Sonic Strategy, a blockchain staking and infrastructure company supporting the Sonic ecosystem.

Spetz Website: www.spetz.app
Sonic Strategy Website: www.sonicstrategy.io
Spetz Investor information: https://investor.spetz.app/

Company Contacts:

Investor Relations Email: Investors@sonicstrategy.io	Mitchell Demeter Email: mitchell@sonicstrategy.io
	Phone: +1-345-936-9555

NEITHER THE CANADIAN SECURITIES EXCHANGE, NOR THEIR REGULATION SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Cautionary Note Regarding Forward-looking Statements
Certain information herein constitutes “forward-looking information” under Canadian securities laws, reflecting management’s expectations regarding objectives, plans, strategies, future growth, results of operations, and business prospects of the Company. Words such as “may”, “plans,” “expects,” “intends,” “anticipates,” “believes,” and similar expressions identify forward-looking statements, which are qualified by the inherent risks and uncertainties surrounding future expectations.

Forward-looking statements are based on a number of estimates and assumptions that, while considered reasonable by management, are subject to business, economic, and competitive uncertainties and contingencies. The Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from projected outcomes. Factors influencing these outcomes include economic conditions, regulatory developments, competition, capital availability, and business execution risks. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur, including, the closing of additional tranches of the Private Placement, how the Company will use of the net proceeds of the Private Placement or if any Warrants or Finder’s Warrants will ever be exercised.

The forward-looking information contained in this press release represents Spetz’s expectations as of the date of this release and is subject to change. Spetz does not undertake any obligation to update forward-looking statements, except as required by law.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, and shall not constitute an offer, solicitation or sale in any state, province, territory or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state, province, territory or jurisdiction. None of the securities issued in the Private Placement will be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act.

We seek Safe Harbor.

SOURCE: Spetz Inc

View the original press release on ACCESS Newswire

Phase 1/2 H5 avian flu vaccine study shows positive interim results

Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines

CAMBRIDGE, MA / ACCESS Newswire / May 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive interim data from a Phase 1/2 clinical study (NCT05972174) evaluating the safety and immunogenicity of its investigational pandemic influenza vaccine, mRNA-1018, in approximately 300 healthy adults aged 18 years and older. The interim results focus on a vaccine candidate targeting the H5 avian influenza virus subtype.

The Company had previously expected to advance the program to late-stage development with the U.S. Department of Health and Human Services (HHS); however, today Moderna received notice that HHS will terminate the award for the late-stage development and right to purchase pre-pandemic influenza vaccines.

“While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis of the Phase 1/2 study of our H5 avian flu vaccine and we will explore alternative paths forward for the program,” said Stéphane Bancel, Chief Executive Officer of Moderna. “These clinical data in pandemic influenza underscore the critical role mRNA technology has played as a countermeasure to emerging health threats.”

The Phase 1/2 study evaluated a two-dose regimen of Moderna’s investigational avian influenza vaccine. mRNA-1018 demonstrated a rapid, potent and durable immune response. At baseline, pre-existing immunity was minimal, with only 2.1% of participants showing hemagglutination inhibition (HAI) antibody titers ≥1:40, an HAI titer considered to correlate with protection. At Day 43, three weeks after the second vaccination, 97.8% of participants achieved titers ≥1:40 with a 44.5-fold increase of titers from baseline.

The investigational vaccine was generally well-tolerated, with no dose-limiting tolerability concerns observed. Most solicited adverse reactions were Grade 1 or 2 and did not increase significantly with number of doses or between first and second doses. Further data is expected to be submitted for presentation at an upcoming scientific meeting.

Moderna will explore alternatives for late-stage development and manufacturing of the H5 program consistent with the Company’s strategic commitment to pandemic preparedness.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the clinical development of mRNA-1018, the safety and immunogenicity data from the Phase 1/2 study; the cancellation of the development contract for Moderna’s pandemic flu program by the U.S. Department of Health and Human Services; and the exploration of alternative paths for development of the vaccine program. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

Moderna Contacts

Media:
Chris Ridley
Global Head of Media Relations
+1 617-800-3651
Chris.Ridley@modernatx.com

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

TEL AVIV, IL / ACCESS Newswire / May 28, 2025 / Over the last few weeks, it’s become increasingly clear that Europe is rethinking its long-held stance on nuclear power. Countries like Denmark, Germany, and Spain are pivoting from prior bans and phase-outs toward the reintegration of nuclear energy into their decarbonization agendas.

The May 27th CNBC report confirmed what many of us in the industry have been anticipating: energy independence and long-term grid stability are now taking priority over political resistance to legacy nuclear policies.

This isn’t just a European trend. In the United States, the nuclear conversation is also heating up. Just last week, the Trump administration issued two executive orders to accelerate the development and deployment of nuclear energy infrastructure. One order clears regulatory red tape for advanced nuclear projects, while the other earmarks new federal support for the deployment of small modular reactors (SMRs) in rural and off-grid communities. Taken together, they signal a dramatic shift toward treating nuclear not as an ideological debate but as a national security and resilience imperative.

As Chief Business Officer of Brenmiller Energy, I view this shift not just as a reversal of prior sentiment but as a turning point for how the world will design and connect energy systems for the next generation. At the center of this new approach is flexibility – a trait nuclear energy alone doesn’t possess. However, it can with thermal energy storage (TES) in its supporting cast.

The Flexibility Problem: Why Baseload Isn’t Enough

Nuclear power excels in providing a consistent baseload of energy. But that strength becomes a liability in today’s dynamic energy market. Grids increasingly require responsive assets that can ramp up or down in real time to match volatile demand curves shaped by solar and wind variability. This is where TES, particularly our bGen™ system, comes into play.

At Brenmiller Energy, we’ve long understood the strategic value of decoupling energy generation from energy consumption. Our thermal storage technology enables energy – whether from renewable sources or nuclear reactors – to be stored as heat and dispatched when needed, 24/7/365.

This unique service isn’t theoretical. Our commercial partnerships and pilot projects, including with ENEL, the largest European energy provider by customer count, Tempo Beverage in Israel, Entelios in Germany, and others, has already proven the reliability and scalability of bGen™ for industrial energy users in a real-world setting. What ENEL saw in the flexible thermal application, and what many utilities are now beginning to understand, is that TES acts as a critical interface between legacy infrastructure and the demands of next-generation systems.

As Europe advances its green hydrogen and renewable integration targets, policymakers are finally confronting the hidden costs of intermittency and grid inflexibility. Nuclear offers dependable generation but not agility. That’s where TES fills the gap. It manages the mismatches between supply and demand, mitigating the risks of repeating the very same rigidity issues that led to nuclear phase-outs in the first place.

From Concept to Commercial Readiness

Consider our recent milestone in Spain: the SolWinHy Cádiz project, an off-grid, green methanol production facility, secured €25 million in funding, with €7 million explicitly allocated to Brenmiller’s bGen™ thermal storage. Why? Because in an island-mode operation that’s disconnected from the national grid, energy flexibility isn’t a luxury. It’s a requirement.

That same logic applies to nuclear. Advanced nuclear reactors are smaller, modular, and more widely deployable. But without a load-following mechanism, they still suffer from the same mismatch between generation capacity and real-time grid needs. TES provides that mechanism.

And serving that need isn’t a far-off vision. With over $40 million in deployable bGen™ infrastructure and a pipeline of global projects underway, Brenmiller Energy is uniquely positioned and able to meet this moment. We believe that with the right supporting technology, like bGen, the nuclear revival on both sides of the Atlantic doesn’t need to clash with the renewable agenda. The two can – and must – work in tandem. However, this will only happen with enabling technologies like TES, which can seamlessly connect these assets into a cohesive, responsive, and resilient energy network.

At Brenmiller Energy, we’re not just watching the shift – we’re helping to power it. As policy evolves, so too must infrastructure. Nuclear energy without flexibility is a missed opportunity. The most excellent news during nuclear’s second chance is that legacy rigidity is no longer a concern. With bGen TES technology included to complement, nuclear gets a foundational building block of the new energy economy.

And as we’ve demonstrated with ENEL, SolWinHy, Tempo Beverage, and others, we’re not just theorizing; we’re putting our innovative assets into practice. We’re proud to say that, as of now, we’re the only known TES provider who can.

By Doron Brenmiller
Chief Business Officer, Brenmiller Energy (NASDAQ:BNRG)

About bGen™

bGen™ ZERO is Brenmiller’s TES system, which converts electricity into heat to power sustainable industrial processes at a price that is competitive with natural gas. The bGen™ ZERO charges by capturing low-cost electricity from renewables or the grid and stores it in crushed rocks. It then discharges steam, hot water, or hot air on demand according to customer requirements. The bGen™ ZERO also supports the development of utility-scale renewables by providing critical flexibility and grid-balancing capabilities. bGen™ ZERO was named among TIME’s Best Inventions of 2023 in the Green Energy category and won Gold in the Energy Storage and Management category at the 2025 Edison Awards.

About Brenmiller Energy Ltd.

Brenmiller Energy helps energy-intensive industries and power producers end their reliance on fossil fuel boilers. Brenmiller’s patented bGen™ ZERO thermal battery is a modular and scalable energy storage system that turns renewable electricity into zero-emission heat. It charges using low-cost renewable electricity and discharges a continuous supply of heat on demand and according to its customers’ needs. The most experienced thermal battery developer on the market, Brenmiller operates the world’s only gigafactory for thermal battery production and is trusted by leading multinational energy companies. For more information visit the Company’s website at https://bren-energy.com/ and follow the company on X and LinkedIn.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the company is using forward-looking statements in this press release when it discusses: that the Company’s bGen™ system installation at Purchase College will reduce 550 metric tons of CO2 emissions annually; that TES modularity enables flexible and efficient deployment across diverse infrastructure; and that as more public entities prioritize net-zero transitions, scalable and proven solutions like our bGen™ can provide a suitable solution. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are intended to identify forward-looking statements. Readers are cautioned that certain crucial factors may affect the company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this press release. Factors that may affect the Company’s results include, but are not limited to: the company’s planned level of revenues and capital expenditures; risks associated with the adequacy of existing cash resources; the demand for and market acceptance of our products; impact of competitive products and prices; product development, commercialization or technological difficulties; the success or failure of negotiations; trade, legal, social and economic risks; and political, economic and military instability in the Middle East, specifically in Israel. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, many of which are beyond the control of the company, including those set forth in the Risk Factors section of the company’s Annual Report on Form 20-F for the year ended December 31, 2024 filed with the SEC on March 4, 2025, which is available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact:

investors@bren-energy.com

SOURCE: Brenmiller Energy

View the original press release on ACCESS Newswire

Clear Start Tax Warns That Tax Debt May Result in Passport Denial or Revocation – and What Taxpayers Can Do About It

IRVINE, CA / ACCESS Newswire / May 28, 2025 / If you owe back taxes to the IRS, your next trip abroad could be in jeopardy. According to Clear Start Tax, a trusted tax resolution firm, the IRS has the legal authority to restrict or revoke a taxpayer’s passport when unpaid federal tax debt reaches a certain threshold.

Under a 2015 law known as the Fixing America’s Surface Transportation (FAST) Act, the IRS can certify “seriously delinquent tax debt” to the U.S. State Department, triggering a block on passport renewal or even revocation. For frequent travelers, business professionals, or anyone planning international travel, the consequences can be both unexpected and severe.

What Counts as “Seriously Delinquent Tax Debt”?

According to IRS guidelines, seriously delinquent tax debt includes:

• An unpaid federal tax balance of $62,000 or more (adjusted annually for inflation)

• A final notice of intent to levy has been issued

• The taxpayer has not entered into a resolution such as an installment agreement or offer in compromise

“Most taxpayers don’t realize that unresolved tax debt can directly impact their ability to travel,” said the Head of Client Solutions at Clear Start Tax. “We’ve assisted clients who were surprised to learn their passport applications were denied due to IRS enforcement-and it often happens at the worst possible time.”

Who Is Most Likely to Face Passport Restrictions?

Clear Start Tax notes that taxpayers most likely to be impacted by passport restrictions include:

• Those with longstanding back tax balances

• Individuals who have ignored multiple IRS notices

• Taxpayers unaware of their debt reaching the enforcement threshold

• Business owners or self-employed individuals with multiple years of unpaid returns

How to Avoid Losing Passport Privileges

Fortunately, travel restrictions can often be lifted once the taxpayer enters into a formal resolution with the IRS. Clear Start Tax helps clients prevent or reverse passport actions through programs such as:

• Installment Agreements – Formal monthly payment plans to regain good standing

• Offer in Compromise (OIC) – Settle the debt for less than what’s owed

• Currently Not Collectible (CNC) status – Pause collections due to financial hardship

• Immediate case review and IRS communication for urgent travel situations

“Passport holds can be resolved-but only if you act before your departure date,” added the Head of Client Solutions. “We help clients resolve tax issues quickly so travel plans aren’t disrupted.”

Clear Start Tax: Helping Taxpayers Stay on Track-And On the Move

Whether you’re planning a vacation, traveling for work, or renewing your passport for future use, tax debt should never be a reason to miss out. Clear Start Tax provides:

• Full IRS account review to assess passport risk

• Resolution strategies tailored to urgency and financial status

• Ongoing compliance support to prevent future restrictions

• Fast-tracked communication with the IRS when timing matters

About Clear Start Tax

Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

Need Help With Back Taxes?
Click the link below:
https://clearstarttax.com/qualifytoday/

Contact Information

Clear Start Tax
Corporate Communications Department
seo@clearstarttax.com
(949) 535-1627

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

NEW YORK CITY, NEW YORK / ACCESS Newswire / May 28, 2025 / FLOKI, the people-powered crypto ecosystem, is going primetime.

In a major national visibility push, FLOKI has entered into a sweeping three-month media partnership with New to The Street, one of the most trusted and widely distributed financial media platforms in the U.S. The campaign will spotlight FLOKI’s dynamic ecosystem-including its flagship MMORPG Valhalla-and its mission to deliver real-world crypto utility to a global audience.

The campaign features:

• Biographical interviews airing nationwide on Fox Business and Bloomberg TV

• Over 150 commercials across CNBC, Bloomberg, and FOX Business

• Times Square billboard dominance (20x per hour)

• Live and virtual investor events targeting brokers, family offices, and accredited investors

• Weekly content distribution to New to The Street’s 2.47M+ YouTube subscribers and across its growing social platforms

“FLOKI is one of the most innovative and community-driven platforms in crypto today,” said New to The Street Founder Vince Caruso. “This campaign ensures they get the national stage and financial audience they deserve.”

From Times Square to Bloomberg: What’s in the Campaign?

Each month, FLOKI leadership will appear in two long-form interviews airing as sponsored programming across Fox Business and Bloomberg TV-reaching over 219 million U.S. households.

FLOKI’s banner and Valhalla visuals will be featured on the Reuters 42nd Street digital billboard, airing 20 times per hour, four weeks a month. The campaign’s creative spotlight centers on the upcoming Valhalla mainnet launch set for June 30, 2025.

Additionally, over 150 commercials per month will run across financial TV networks, with a secondary Bloomberg commercial push beginning in month two. The partnership also includes 3 monthly press releases, NYSE interview recaps, and earned media syndication across ABC, NBC, CBS, and FOX affiliate networks.

FLOKI will also participate in:

• Broker-hosted meet-and-greet events

• Intimate investor dinners in NYC

• Virtual presentations for family offices and accredited investors

“I’m very excited about this partnership and sharing how FLOKI is making blockchain better than we found it,” said Pedro Vidal, FLOKI’s Community Relations Officer. “This campaign expands our reach and reveals the powerful utility within the FLOKI ecosystem. I’m dually proud and excited!”

About FLOKI

FLOKI is the people’s cryptocurrency and utility token of the Floki Ecosystem. With over 550,000 holders, FLOKI aims to be the world’s most recognized and widely used cryptocurrency, driven by utility, philanthropy, community, and marketing. Its global brand has been featured in strategic campaigns reaching billions.

floki.com
@RealFlokiInu

About TokenFi

TokenFi is FLOKI’s sister project focused on simplifying crypto and asset tokenization. With a no-code interface, TokenFi empowers users to launch or tokenize real-world assets with ease, targeting the trillion-dollar tokenization market.

tokenfi.com
@tokenfi

About Valhalla

Valhalla is FLOKI’s metaverse blockchain-based MMORPG, inspired by Norse mythology. Players discover, tame, and battle creatures called Veras in a player-driven economy. The mainnet launch is slated for June 30, 2025.

valhalla.game

About New to The Street

New to The Street is a premier financial media brand known for its weekly long-form interviews with CEOs, innovators, and emerging public and private companies. Broadcasting as sponsored programming on Bloomberg and Fox Business, New to The Street reaches over 219 million households weekly, in addition to its 2.51M+ YouTube subscribers and 714K+ social media followers across LinkedIn, Twitter, Instagram, and Facebook. The brand also delivers earned media pickup on ABC, NBC, and CBS affiliates and dominates outdoor exposure in NYC with billboards in Times Square and the Financial District.

Website: newtothestreet.com

Media Contact: Monica@NewtoTheStreet.com

SOURCE: New To The Street

View the original press release on ACCESS Newswire

CHICAGO, IL / ACCESS Newswire / May 28, 2025 / The proliferation of fake documents generated by artificial intelligence has reached a critical level. From diplomas to bank powers of attorney, purchase orders, emails, and press releases, everyone is now exposed to significant legal, financial, and reputational risks.

In regulated sectors such as banking and finance, press releases must be authentic, timestamped, and tamper-proof. That is exactly what Certidox provides: ensuring that any content published by an organization – including official communications – remains authentic, traceable, and immune to sophisticated forgery attempts.

This technology will be presented by Rémy EISENSTEIN on May 29 at the ULCC Networking Extravaganza held at the Union League Club of Chicago.

Certidox enables instant verification of the authenticity of any document – paper or digital – and ensures ongoing monitoring through real-time alerts in case of changes or revocation. Based on patented end-to-end encryption and operating without any third-party trust, Certidox guarantees absolute confidentiality: no data is ever stored in plain text on its servers.

Thanks to its open-source code, Certidox also provides total transparency: it can be freely audited, verified, and integrated into any IT system.

The applications of Certidox technology are numerous:

• For everyone: email content

• For banks: account holder attestations, payment instructions, credit documents

• For law firms and notaries: powers of attorney, contracts, court rulings

• For businesses: purchase orders, quotes, regulated press releases

• For education: diplomas, transcripts, certificates (as demonstrated with the TrustDiplomas application)

“In a world where everything can be copied, altered, or forged in seconds by artificial intelligence, we offer a sovereign, transparent, and tamper-proof solution. Certidox restores value to documentary proof,” says Rémy EISENSTEIN, Founder.

Press Contact:
Rémy A. EISENSTEIN – remy@certidox.com
+1 (630) 895-4089
https://certidox.com

SOURCE: Certidox

Related Documents:

• pressreleasecertidoxcertified

View the original press release on ACCESS Newswire

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study in neuropathic pain, and finalizes filings for SKNY acquisition.

MIAMI, FL / ACCESS Newswire / May 28, 2025 / MIRA Pharmaceuticals, Inc. (Nasdaq:MIRA) (“MIRA” or the “Company”), a clinical-stage pharmaceutical company developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced that it will participate in the BIO International Convention 2025, taking place in Boston, MA from June 16-19, 2025. The Company has a full schedule of BIO One-on-One Partnering™ meetings planned as it explores potential licensing, strategic partnerships, and M&A opportunities.

The Company’s lead candidate, Ketamir-2, a next-generation oral ketamine analog, is currently undergoing a Phase 1 clinical trial. With the second dosing cohort completed, the Company is now preparing to initiate the third cohort. Building on this momentum, MIRA anticipates initiating a Phase IIa study in neuropathic pain before the end of the year, advancing the development of what the Company believes could be a safe, effective non-opioid alternative for chronic pain management.

In addition, MIRA is advancing a series of preclinical studies with Ketamir-2, including models evaluating its potential in PTSD, as well as a topical formulation aimed at treating localized inflammatory pain. The Company is also finalizing regulatory filings related to its acquisition of SKNY Pharmaceuticals, Inc. (“SKNY”), with submission to the U.S. Securities and Exchange Commission (SEC) expected in the coming weeks. SKNY-1, SKNY’s primary pharmaceutical candidate, is being developed as an oral therapeutic targeting smoking cessation and obesity, with activity at CB1, CB2, and MAO-B receptors.

“Our pipeline is advancing on all fronts, and we are focused on turning this scientific momentum into long-term value for patients and shareholders,” said Erez Aminov, Chief Executive Officer of MIRA. “As we move closer to initiating Phase IIa and completing the SKNY transaction, we’re actively exploring strategic opportunities to accelerate growth, including licensing and partnerships-especially in areas like chronic pain where non-opioid alternatives like Ketamir-2 are urgently needed.”

Dr. Angel, Chief Scientific Advisor at MIRA, added:
“We believe Ketamir-2 is paving the way for a new class of non-opioid therapies. The science is compelling, and the progress we have made is truly exciting. I look forward to sharing the depth of our work and the promising data we’ve generated with potential partners and investors.”

Cautionary Note Regarding Forward-Looking Statements
This press release and the statements of MIRA’s management related thereto contain “forward-looking statements,” which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any statements in this press release that are not historical facts may be deemed forward-looking. Any forward-looking statements in this press release are based on MIRA’s current expectations, estimates, and projections only as of the date of this release and are subject to a number of risks and uncertainties (many of which are beyond MIRA’s control) that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements, including related to MIRA’s potential merger with SKNY Pharmaceuticals, Inc. These and other risks concerning MIRA’s programs and operations are described in additional detail in the Annual Report on Form 10-K for the year ended December 31, 2024, and other SEC filings, which are on file with the SEC at www.sec.gov and MIRA’s website at https://www.mirapharmaceuticals.com/investors/sec-filings. MIRA explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

Contact Information
Helga Moya
info@mirapharma.com
(786) 432-9792

SOURCE: MIRA Pharmaceuticals

View the original press release on ACCESS Newswire

• Sublingual nano technology delivers caffeine rapidly to the blood stream, bringing its unique disruptive benefits to the Pre-workout market

• Initial production has commenced with six flavor options

• Expanded pre-launch consumer testing planned for Q2 2025

• Aspire to launch BUZZ BOMB™ at two major upcoming fitness conventions

• Marketing plan focused on cost-effective multi-channel digital strategy targeting primary influencers, direct response sales and traditional retail sales channels

• Global pre-workout supplements market size is expected to reach $27.97 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030

HUMACO, PUERTO RICO and NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today announced the brand name BUZZ BOMB™ and anticipated market launch for its novel sublingual pre-workout supplement. BUZZ BOMB™ features 50mg of caffeine and is designed to support sustained energy and mental focus, helping athletes and fitness enthusiasts maximize their performance potential.

Aspire has commenced initial production of BUZZ BOMB™, its single serving pre-workout caffeine supplement utilizing Aspire’s patent-pending and proprietary sublingual delivery technology.The pre-workout formula is conveniently packaged in a single serving packet for easy on-the-go use. Consumers will have a choice of six BUZZ BOMB™ flavors, including Tropical Fruit, Mixed Berry, Watermelon, Lemon Lime, Peach Mango, and Mocha Coffee.

Fitness Convention Booth and Sponsor Events for BUZZ BOMB™ Launch

The Company expects to begin expanded pre-launch consumer testing of this supplement product during the second quarter of 2025. In August, the Company will have a booth and be an event sponsor at two of the largest fitness conferences in the nation where over 50,000 people interested in health, fitness, optimization, nutrition, and overall wellbeing will be able to taste, sample, and experience the BUZZ BOMB™ pre-workout supplement.

FITCON Expo
https://fitcon.com/

August 1-2, 2025
Mountain America Expo Center, Salt Lake City, Utah

The Fit Expo™
https://thefitexpo.com/cities/anaheim/
August 2-3
The Anaheim Convention Center, Anaheim, CA

Management Commentary

“The introduction of Aspire’s caffeine-based “Buzz Bomb™” Sublingual Pre-Workout energy supplement has the ideal unique characteristics to disrupt the fast-growing, multi-billion-dollar Sports Nutrition and Fitness market,” said Kraig Higginson, Chief Executive Officer of Aspire. “We are excited about the early feedback from fitness trainers and athletes-who love how clean and simple our product is–and we look forward to the implementation of our phased marketing plan as we prepare for our market launch in the early third quarter. Initial production, performed by Desert Stream, a leading private label manufacturer in the health and wellness industry, has proceeded as planned and we expect to have ample product available for consumer testing and launch.

While we are initially focused on the fitness pre-workout market, we believe the product also has tremendous broad market appeal in the Cognitive Focus and Energy Boost markets for professionals seeking a safe, healthy way to meet energy demands at work. We believe it may also appeal to a growing Health and Nutrition market as a weight loss enhancement, and as a coffee alternative, providing the taste, energy, and cognitive boost of coffee, while on the go, without the adverse effects of disrupting the gut micro biome and the liver, that is associated with long term coffee consumption.”

Higginson added, “As part of our commercial and revenue strategy, BUZZ BOMB™, is expected to provide Aspire with the opportunity for rapid, cost-effective market entry, and early revenue and cash flow while we complete our FDA clinical trials and application process for our high-dose aspirin product.”

BUZZ BOMB™: Disruptive Characteristics

The Pre-Workout supplement market segment is flooded with many options for energy boosting and hydration products. Many, if not most, of these products today are based on a powdered “mix + water” combination that take 20-30 minutes to digest and begin to provide performance benefits. This disadvantage complicates use, response management, caffeine control, and effectiveness. In contrast, Buzz Bomb™ provides nearly instant energy, in easy-to-use small sublingual packets, which can be taken right before and during work out as needed.

Market research shows that immediacy, ease of use and time management (take as needed, when needed) ranks highest in consumer preferences. Buzz Bomb™ offers potentially disruptive benefits and product characteristics that is expected to drive market penetration with significant differentiation, leading to rapid customer conversion, acquisition, and brand identity in this market.

Aspire’s sublingual nano technology is designed to deliver caffeine directly to the blood stream, bringing its unique disruptive benefits to the Pre-Workout market. These unique benefits provide significant product differentiation from powder mix beverage products that currently dominate the market segment.

BUZZ BOMB™ Disruptive Features:

• Speed – works nearly immediately vs. 20-30 minutes

• Convenience – easy to use small packets vs. mix beverages

• Energy management – use as needed, when needed to manage energy

• Single Safe Ingredients – well known benefits and use of caffeine

• Low manufacturing & packaging costs – competitive pricing with high margin potential

• Easy powerful product demonstration – enabling low-cost sample kits

Pre-workout Supplements Market & Growth Drivers

According to Research and Market Reports recent report, “The global pre-workout supplements market size is expected to reach $27.97 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030.”

Growth Drivers

• Rising fitness culture and gym memberships

• Consumer focus on performance and recovery

• Expanding demographics (women, Gen Z, casual exercisers)

• Growth of RTD (“Ready To Drink”- no mixing) formats & natural formulations

• Digital fitness and influencer-led marketing

About the Aspire Targeted Oral Delivery Platform

Aspire’s technology delivers a soluble, fast acting granular or powder formulation which has been developed by using our patent-pending methodology, and “trade secret” process. The technology’s new mechanism of action allows for rapid sublingual absorption and entry into the bloodstream of supplements and other substances. The benefits of “rapid absorption” are to provide rapid impact in more precise quantities.

About Aspire Biopharma, Inc.

Headquartered in Humacao, Puerto Rico, Aspire Biopharma has developed a disruptive technology through a Novel Soluble Formulation which can deliver supplements and drugs rapidly and precisely. For more information, please visit www.aspirebiolabs.com.

Safe Harbor Statement

Certain statements made in this communication are “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as “estimate,” “projects,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “would,” “should,” “future,” “propose,” “potential,” “target,” “goal,” “objective,” “outlook” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Aspire Biopharma Holdings, Inc.

Contact

TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com

SOURCE: Aspire Biopharma Holdings, Inc.

View the original press release on ACCESS Newswire